Live data from Hacker News

Viewing profile — mjewkes

mjewkes

HN member
Joined
Fri, Jul 27, 2012, 4:38 PM UTC
HN karma
138
Public activity
79 items

About mjewkes

No profile information was provided.

Recent public activity

  1. comment
    Comment #48113681

    >an awful lot of modern professional life consists of producing artifacts whose primary audience is other people producing artifacts. Slide decks for slide decks, strategy document…

  2. comment
  3. comment
    Comment #43558885

    Sure, they can build it here—but protectionism doesn’t deliver long-term success. In the short term, it drives up prices and makes consumers poorer. In the long run, tariffs shield…

  4. comment
    Comment #43065756

    How do you get 55%? Wikipedia says 49.8%. https://en.wikipedia.org/wiki/2024_United_States_presidentia...

  5. comment
  6. comment
    Comment #42012671

    CAR-T may have a ~50% cure rate for blood cancers: https://ashpublications.org/blood/article/141/19/2307/494672...

  7. comment
    Comment #41941865

    I agree completely with the first part. But SWA-1380 was a commercial operating fatality in 2018. Not a crash into terrain, but the engine definitely crashed into the fuselage.

  8. comment
    Comment #41875929

    Centrifugal forces on the spinning object will tear it apart once it goes “really fast”

  9. comment
    Comment #40598169

    The FDA approves new modalities that do things “in their own way” all of the time! Yescarta, Kymriah, the mRNA vaccines, the approved VHH, scVF and “mimetics” in the article. Here’…

  10. comment
    Comment #40593595

    >I can say this with pretty strong confidence: had the FDA not being so strict about its trials, lots of these experimental type of antibodies would have already received massived …

  11. comment
    Comment #40567109

    If you are truly netflix-to-be, you should be able to affordably incentivize your 12 key employees with equity. An exit for Employee < 50 at a netflix-to be will be in the hundreds…

  12. comment
    Comment #40201605

    Apples are better than bananas. Cherries are worse than apples. Are cherries better than bananas? -- GPT-4 - wrong gpt2-chatbot - wrong Claude 3 Opus - correct

  13. comment
    Comment #40017554

    Notably, if you ask it to transform the statements to formal logic, you get a correct response! This stuff is truly magic. https://chat.openai.com/share/81e45fef-a72b-4258-98d6-5c8…

  14. comment
    Comment #40017517

    For sure. It's not a fair prompt at all. I'm super bullish on LLMs and am using GPT-4 in production right now. This stuff is magic. It's actually hard to find short, simple, "plain…

  15. comment
    Comment #40016369

    My current favorite “LLM breaker” below. GPT4, Claude, and this all fail. —- Apples are better than bananas. Cherries are worse than apples. Are cherries better than bananas?

  16. comment
    Comment #37696842

    Editorial write-up: https://archive.ph/0T2XI

  17. story
  18. comment
    Comment #35941691

    Worth checking out the talk page. Looks like this whole article is out of date and that much of the problem is resolved.

  19. comment
    Comment #34306299

    This seems credible: https://ascopubs.org/doi/full/10.1200/EDBK_288015

  20. comment
    Comment #34306240

    As fabiancook mentions, credible sources all end up on pubmed within a year or two of publication, so it's an excellent resource. That said, Pubmed is an aggregator, not a curator.…

  21. comment
    Comment #31553128

    https://www.rand.org/pubs/research_briefs/RB9412.html and The Great American Drug Deal, by Peter Kolchinsky. Specific claims: - The US pays more for new drugs than the rest of the …

  22. comment
    Comment #31553124

    No assumptions. The rand article addresses that directly.

  23. comment
    Comment #31551607

    Hey biorach - I would suggest: https://www.rand.org/pubs/research_briefs/RB9412.html and The Great American Drug Deal, by Peter Kolchinsky. Specific claims: - The US pays more for …

  24. comment
    Comment #31551572

    The claim is largely true for drug development, but not for routine procedures. Those are expensive for unrelated, and largely pathological, reasons. I would suggest: https://www.r…

  25. comment
    Comment #31551563

    The claim is largely true for drug development, but not for routine procedures. Those are expensive for unrelated, and largely pathological, reasons.